NASDAQ: VTVT
Vtv Therapeutics Inc Stock Ownership - Who owns Vtv Therapeutics?

Insider buying vs selling

Have Vtv Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Srinivas AkkarajuDirector2025-09-22106,000$15.27
$1.62MBuy

1 of 1

VTVT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTVT insiders and whales buy or sell their stock.

VTVT Shareholders

What type of owners hold Vtv Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ronald O. Perelman988.15%38,919,878$1.30BInsider
G42 Investments Ai Holdings Rsc Ltd263.70%10,386,274$345.66MInsider
Tahnoon Bin Zayed S. Alnahyan263.70%10,386,274$345.66MInsider
Srinivas Akkaraju7.94%312,784$10.41MInsider
Samsara Biocapital LLC7.58%298,496$9.93MInstitution
Fmr LLC6.83%268,856$8.95MInstitution
Trails Edge Capital Partners LP5.86%231,000$7.69MInstitution
Samsara Biocapital GP LLC5.25%206,784$6.88MInsider
Siren LLC4.14%163,000$5.42MInstitution
Baker Bros Advisors LP3.77%148,314$4.94MInstitution

1 of 3

VTVT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTVT2.07%97.93%Net Buying
UNCY37.90%21.29%
CNTB15.14%1.03%
TLSA2.64%0.00%
IMUX39.30%12.50%Net Buying

Vtv Therapeutics Stock Ownership FAQ

Who owns Vtv Therapeutics?

Vtv Therapeutics (NASDAQ: VTVT) is owned by 32.59% institutional shareholders, 1,539.69% Vtv Therapeutics insiders, and 0.00% retail investors. Ronald O. Perelman is the largest individual Vtv Therapeutics shareholder, owning 38.92M shares representing 988.15% of the company. Ronald O. Perelman's Vtv Therapeutics shares are currently valued at $1.48B.

If you're new to stock investing, here's how to buy Vtv Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.